Correlation studies with serum anti‐PLA2R antibodies, glomerular PLA2R deposition, and proteinuria findings in patients with PMN, as well as cases, suggest that hypercholesterolemia may be a potential biomarker for predicting the severity of PMN.227, 228. The gene discussed is PLA2R1; the disease is Hypercholesterolemia.